Astellas Pharma Inc, YPH:FRA profile

Health CarePharmaceuticals and Biotechnology

Price (EUR)9.20
Today's Change0.446 / 5.09%
Shares traded200.00
1 Year change-32.35%
Beta--

Data delayed at least 15 minutes, as of May 02 2024 07:35 BST.

More ▼

Add to Your Portfolio

Name

Currency

Profile data is unavailable for this security.

About the company

Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.

Revenue in JPY (TTM)1.60tn
Net income in JPY17.05bn
Incorporated1939
Employees14.48k

Location
Astellas Pharma Inc2-5-1, Nihombashihon-choCHUO-KU 103-8411JapanJPN
Phone+81 332443000
Websitehttps://www.astellas.com/

More ▼

Mergers & acquisitions

Acquired company	Deal status	Date	Date / Deal status	4503:TYO since announced	Transaction value
Propella Therapeutics Inc	Deal completed	15 Nov 2023	15 Nov 2023Deal completed	-11.25%	175.00m

Data delayed at least 20 minutes, as of May 02 2024 07:00 BST.

Income statement (JPY)

Year on year Astellas Pharma Inc had net income fall -82.73% from 98.71bn to 17.05bn despite a 5.60% increase in revenues from 1.52tn to 1.60tn. An increase in the selling, general and administrative costs as a percentage of sales from 41.50% to 46.15% was a component in the falling net income despite rising revenues.

Explore our tools

Growth CalculatorBETA
Explore the time value of money, the impact of regular contributions, and the power of saving over longer timeframes
Alerts
Create detailed alerts and get notified the moment an event happens
Watchlists
Monitor a select list of assets
Are you sure you want to cancel?
Portfolio
See how trades would have performed from years past or start from the present
Data archive
Download PDF copies of reports from the newspaper markets data page
World markets
View the performance of global markets and browse news items by region
Equities screener
Find companies based on country, sector, and other equity characteristics
Funds overview
View funds that move the market, screen for funds and read relevant news

Data Provided by LSEG

All markets data located on FT.com is subject to the FT Terms & Conditions

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Astellas Pharma Inc

Select symbol

Astellas Pharma Inc

ApplyActions

Your alerts

About the company

Mergers & acquisitions